Global autoinjectors market is anticipated to grow at an impressive growth in the next five years owing its growth to the factors like rising prevalence of the targeted therapies, along with the rising cases of anaphylaxis at an alarming rate. The market is expected to register a double digit CAGR in the forecast period, 2022-2026. Moreover, patients in a comparative stable state are preferring self-administrations of the drug, with its advantages on usability, the factors are driving the global autoinjector market growth, positively. The market observes an increasing number of regulatory approvals looking at the feasibility of the device for the patients, this factor is also boosting the market growth.

Government support toward the favorable reimbursements, and technological advancements of the device like dosage monitoring are growth favoring factors. New players may invest in the research and development of the enhanced and better versions of the devices thereby increasing the market shares. The market also fears a minor challenge of alternate routes of drug delivery like oral administrations, or nasal sprays. They pose a threat toward the growth of the market which can be overcome by technological advancements.

The global autoinjector market is segmented by therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitional landscape. Based on therapy the market is further segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. Anaphylaxis is a life-threatening infectious disease, that takes place as an allergic reaction of food, drugs, latex, and Hymenoptera stings. The cases of anaphylaxis is rising rapidly and thereby assures the largest market of the sub-segment in the future five years. Patients have registered infection and allergic reaction to even general anesthesia, making it almost impossible scenarios for a general surgical procedure. US, UK, and Australia have registered maximum cases of anaphylaxis.

Some of the major competitors in the market are Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, Medeca Pharma AB, among others. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global autoinjectors market from 2016 to 2019.
  • To estimate and forecast the market size of global autoinjectors market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast global autoinjectors market based on therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global autoinjectors market.
  • To identify drivers and challenges for global autoinjectors market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoinjectors market.
  • To identify and analyze the profile of leading players operating in global autoinjectors market.
  • To identify key sustainable strategies adopted by market players in global autoinjectors market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global autoinjectors market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, service providers and other stakeholders
  • Distributers and suppliers of autoinjectors products and other stakeholders
  • Organizations, forums, and alliances related to autoinjectors market   
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global autoinjectors market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Autoinjectors Market, By Therapy:
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Diabetes
    • Anaphylaxis
    • Others
  • Global Autoinjectors Market, By Design:
    • Standardized
    • Customized
  • Global Autoinjectors Market, By Product:
    • Prefilled
    • Fillable
  • Global Autoinjectors Market, By Technology:
    • Automated
    • Manual
  • Global Autoinjectors Market, By Type:
    • Disposable
    • Reusable
  • Global Autoinjectors Market, By Route of Administrations:
    • Intravenous
    • Subcutaneous
  • Global Autoinjectors Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Care Settings
    • Home Care Settings
  • Global Autoinjectors Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoinjectors market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Autoinjectors Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Autoinjectors Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Autoinjectors Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others)

6.2.2.     By Design (Standardized v/s Customized)

6.2.3.     By Product (Prefilled v/s Fillable)

6.2.4.     By Technology (Automated v/s Manual)

6.2.5.     By Type (Disposable v/s Reusable)

6.2.6.     By Route of Administration (Intravenous v/s Subcutaneous)

6.2.7.     By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings)

6.2.8.     By Company (2020)

6.2.9.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Autoinjectors Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Design

7.2.3.     By Product

7.2.4.     By Technology

7.2.5.     By Type

7.2.6.     By Route of Administration

7.2.7.     By End User

7.2.8.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Autoinjectors Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Design

7.3.1.2.3.             By Product

7.3.1.2.4.             By Technology

7.3.1.2.5.             By Type

7.3.1.2.6.             By Route of Administration

7.3.1.2.7.             By End User

7.3.2.     India Autoinjectors Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Design

7.3.2.2.3.             By Product

7.3.2.2.4.             By Technology

7.3.2.2.5.             By Type

7.3.2.2.6.             By Route of Administration

7.3.2.2.7.             By End User

7.3.3.     South Korea Autoinjectors Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Design

7.3.3.2.3.             By Product

7.3.3.2.4.             By Technology

7.3.3.2.5.             By Type

7.3.3.2.6.             By Route of Administration

7.3.3.2.7.             By End User

7.3.4.     Japan Autoinjectors Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Therapy

7.3.4.2.2.             By Design

7.3.4.2.3.             By Product

7.3.4.2.4.             By Technology

7.3.4.2.5.             By Type

7.3.4.2.6.             By Route of Administration

7.3.4.2.7.             By End User

7.3.5.     Australia Autoinjectors Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Therapy

7.3.5.2.2.             By Design

7.3.5.2.3.             By Product

7.3.5.2.4.             By Technology

7.3.5.2.5.             By Type

7.3.5.2.6.             By Route of Administration

7.3.5.2.7.             By End User

8.    Europe Autoinjectors Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Design

8.2.3.     By Product

8.2.4.     By Technology

8.2.5.     By Type

8.2.6.     By Route of Administration

8.2.7.     By End User

8.2.8.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Autoinjectors Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Design

8.3.1.2.3.             By Product

8.3.1.2.4.             By Technology

8.3.1.2.5.             By Type

8.3.1.2.6.             By Route of Administration

8.3.1.2.7.             By End User

8.3.2.     Germany Autoinjectors Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Design

8.3.2.2.3.             By Product

8.3.2.2.4.             By Technology

8.3.2.2.5.             By Type

8.3.2.2.6.             By Route of Administration

8.3.2.2.7.             By End User

8.3.3.     United Kingdom Autoinjectors Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Design

8.3.3.2.3.             By Product

8.3.3.2.4.             By Technology

8.3.3.2.5.             By Type

8.3.3.2.6.             By Route of Administration

8.3.3.2.7.             By End User

8.3.4.     Italy Autoinjectors Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapy

8.3.4.2.2.             By Design

8.3.4.2.3.             By Product

8.3.4.2.4.             By Technology

8.3.4.2.5.             By Type

8.3.4.2.6.             By Route of Administration

8.3.4.2.7.             By End User

8.3.5.     Spain Autoinjectors Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapy

8.3.5.2.2.             By Design

8.3.5.2.3.             By Product

8.3.5.2.4.             By Technology

8.3.5.2.5.             By Type

8.3.5.2.6.             By Route of Administration

8.3.5.2.7.             By End User

9.    North America Autoinjectors Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By Design

9.2.3.     By Product

9.2.4.     By Technology

9.2.5.     By Type

9.2.6.     By Route of Administration

9.2.7.     By End User

9.2.8.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Autoinjectors Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapy

9.3.1.2.2.             By Design

9.3.1.2.3.             By Product

9.3.1.2.4.             By Technology

9.3.1.2.5.             By Type

9.3.1.2.6.             By Route of Administration

9.3.1.2.7.             By End User

9.3.2.     Mexico Autoinjectors Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapy

9.3.2.2.2.             By Design

9.3.2.2.3.             By Product

9.3.2.2.4.             By Technology

9.3.2.2.5.             By Type

9.3.2.2.6.             By Route of Administration

9.3.2.2.7.             By End User

9.3.3.     Canada Autoinjectors Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapy

9.3.3.2.2.             By Design

9.3.3.2.3.             By Product

9.3.3.2.4.             By Technology

9.3.3.2.5.             By Type

9.3.3.2.6.             By Route of Administration

9.3.3.2.7.             By End User

10.  South America Autoinjectors Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By Design

10.2.3.  By Product

10.2.4.  By Technology

10.2.5.  By Type

10.2.6.  By Route of Administration

10.2.7.  By End User

10.2.8.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Autoinjectors Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapy

10.3.1.2.2.           By Design

10.3.1.2.3.           By Product

10.3.1.2.4.           By Technology

10.3.1.2.5.           By Type

10.3.1.2.6.           By Route of Administration

10.3.1.2.7.           By End User

10.3.2.  Argentina Autoinjectors Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapy

10.3.2.2.2.           By Design

10.3.2.2.3.           By Product

10.3.2.2.4.           By Technology

10.3.2.2.5.           By Type

10.3.2.2.6.           By Route of Administration

10.3.2.2.7.           By End User

10.3.3.  Colombia Autoinjectors Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapy

10.3.3.2.2.           By Design

10.3.3.2.3.           By Product

10.3.3.2.4.           By Technology

10.3.3.2.5.           By Type

10.3.3.2.6.           By Route of Administration

10.3.3.2.7.           By End User

11.  Middle East and Africa Autoinjectors Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Therapy

11.2.2.  By Design

11.2.3.  By Product

11.2.4.  By Technology

11.2.5.  By Type

11.2.6.  By Route of Administration

11.2.7.  By End User

11.2.8.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Autoinjectors Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Therapy

11.3.1.2.2.           By Design

11.3.1.2.3.           By Product

11.3.1.2.4.           By Technology

11.3.1.2.5.           By Type

11.3.1.2.6.           By Route of Administration

11.3.1.2.7.           By End User

11.3.2.  Saudi Arabia Autoinjectors Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Therapy

11.3.2.2.2.           By Design

11.3.2.2.3.           By Product

11.3.2.2.4.           By Technology

11.3.2.2.5.           By Type

11.3.2.2.6.           By Route of Administration

11.3.2.2.7.           By End User

11.3.3.  UAE Autoinjectors Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Therapy

11.3.3.2.2.           By Design

11.3.3.2.3.           By Product

11.3.3.2.4.           By Technology

11.3.3.2.5.           By Type

11.3.3.2.6.           By Route of Administration

11.3.3.2.7.           By End User

11.3.4.  Kuwait Autoinjectors Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Therapy

11.3.4.2.2.           By Design

11.3.4.2.3.           By Product

11.3.4.2.4.           By Technology

11.3.4.2.5.           By Type

11.3.4.2.6.           By Route of Administration

11.3.4.2.7.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Mylan N.V.

14.2.              AbbVie Inc.

14.3.              Eli Lilly and Company

14.4.              Ypsomed Holding AG

14.5.              Amgen Inc.

14.6.              Becton, Dickinson, and Company

14.7.              GlaxoSmithKline plc

14.8.              Johnson & Johnson International, Inc.

14.9.              Teva Pharmaceutical Industries Ltd

14.10.            Antares Pharma, Inc.

14.11.            Merck KGaA

14.12.            F. Hoffmann-LA Roche

14.13.            Bayer AG

14.14.            Bristol-Myers Squibb Company

14.15.            Medeca Pharma AB

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com